Intensive insulin therapy improves the survival probability of non-diabetic COVID-19 patients presenting with acute hyperglycemia

References

• Liu D, Tang Y, Zhang Q. Admission Hyperglycemia Predicts Long-Term Mortality in Critically Ill Patients With Subarachnoid Hemorrhage: a Retrospective Analysis of the MIMIC-III Database. Front Neurol. 2021 Oct 5;12: 678998.
   Web of Science ®Google Scholar
• Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes. 2021 Jul 15;12(7):1026–1041.
   Web of Science ®Google Scholar
• Zeitoun M, Abdel-Rahim A, Hasanin M, et al. A prospective randomized trial comparing computerized columnar insulin dosing chart (the Atlanta protocol) versus the joint British diabetes societies for inpatient care protocol in management of hyperglycemia in patients with acute coronary syndrome admitted to cardiac care unit in Alexandria. Egypt. Diabetes Metab Syndr. 2021 May-Jun;15(3):711–718.
   Web of Science ®Google Scholar
• Azab M, Hasaneen S, Hanifa H, et al. Optic neuritis post-COVID-19 infection. A case report with meta-analysis. Interdiscip Neurosurg. Dec 2021;26:101320.
   Google Scholar
• Geravandi S, Mahmoudi-aznaveh A, Azizi Z, et al. SARS-CoV-2 and pancreas: a potential pathological interaction? Trends Endocrinol Metab. 2021 Nov;32(11):842–845.
   Web of Science ®Google Scholar
• Vranić L, Radovan A, Poropat G, et al. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas). 2021 Oct 3;57(10):1057.
   Web of Science ®Google Scholar
• Hammoudeh S, Hammoudeh A, Bhamidimarri P, et al. Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World J Gastroenterol. 2021 Jun 7;27(21):2850–2870.
   Web of Science ®Google Scholar
• Gómez-Zorita S, Milton-Laskibar I, García-Arellano L, et al. An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity. Int J Mol Sci. 2021 Jul 26;22(15):7975.
   Web of Science ®Google Scholar
• De Ligt M, Hesselink M, Jorgensen J, et al. Resveratrol supplementation reduces ACE2 expression in human adipose tissue. Adipocyte. 2021 Dec;10(1):408–411.
   PubMed Web of Science ®Google Scholar
• Reiterer M, Rajan M, Gómez-Banoy N, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021 Sep 16;33(11):2174–2188.e5.
   Web of Science ®Google Scholar
• Gammone MA, D’Orazio N. COVID-19 and Obesity: overlapping of Two Pandemics. Obes Facts. 2021 Sep 24; 1–7. 10.1159/000518386.
   Web of Science ®Google Scholar
• Al-Kuraishy H, Al-Gareeb A, Alblihed M, et al. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Front Cardiovasc Med. 2021 May 20;8: 644095.
   PubMed Web of Science ®Google Scholar
• Bray GA. Pathophysiology of obesity. Am J Clin Nutr. 1992;55(2):488S–94S.
   PubMed Web of Science ®Google Scholar
• https://www.google.com/search?q=severity+of+covid+19&oq=severit&aqs=chrome.3.0i457j0j69i57j0l2.5858j0j4&client=ms-android-samsung-gn-rev1&sourceid=chrome-mobile&ie=UTF-8
   Google Scholar
• Moghissi E, Korytkowski M, DiNardo M, et al. American Association of Clinical Endocrinologists, American Diabetes Association: american Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009 Jun;32(6):1119–1131.
   PubMed Web of Science ®Google Scholar
• Tinder P. Determination of blood glucose. Ann Clin Biochem. 1969;6:24.
   Google Scholar
• Liang W, Liang H, Ou L, et al. China Medical Treatment Expert Group for COVID-19: development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 Aug 1;180(8):1081–1089.
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wouters P, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003 Feb;31(2):359–366.
   PubMed Web of Science ®Google Scholar
• Montefusco L, Nasr M, D’Addio F, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021 Jun;3(6):774–785.
   PubMedGoogle Scholar
• Gómez A, Henao D, Muñoz O, et al. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19. Diabetes Metab Syndr. 2021 Mar-Apr;15(2):499–503.
   Web of Science ®Google Scholar
• Ilias I, Diamantopoulos A, Pratikaki M, et al. Dimopoulou I: glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients. Medicina (Kaunas). 2021 Jan 14;57(1):68.
   PubMed Web of Science ®Google Scholar
• Lopez-Huamanrayme E, Garate-Chirinos D, Espinoza-Morales F, et al. Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital: a retrospective cohort study. J Clin Transl Endocrinol. 2021Dec;26:100265.
   Google Scholar
• Lazzeri C, Bonizzoli M, Batacchi S, et al. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome. Diabetes Res Clin Pract. 2021May;175:108789.
   Web of Science ®Google Scholar
• Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020 Dec;12(12):895–908.
   PubMed Web of Science ®Google Scholar
• Carrasco-Sánchez F, López-Carmona M, Martínez-Marcos F, et al. SEMI-COVID-19 Network: admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021 Dec;53(1):103–116.
   PubMed Web of Science ®Google Scholar
• Fadini G, Morieri M, Boscari F, et al. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract. 2020Oct;168:108374.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li C, Xu Y, et al. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediators Inflamm. 2021 Mar 18;2021: 8812304.
   Web of Science ®Google Scholar
• Lee H, Sajan A, Tomer Y. Hyperglycemic Emergencies Associated With COVID-19 Vaccination: a Case Series and Discussion. J Endocr Soc. 2021 Sep 25;5(11):bvab141.
   PubMed Web of Science ®Google Scholar
• Steenblock C, Richter S, Berger I, et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021 Jun 10;12(1):3534.
   PubMed Web of Science ®Google Scholar
• Lima-Martínez M, Boada C, Madera-Silva M, et al. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2020 May-Jun;33(3):151–157.
   Web of Science ®Google Scholar